Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Cuts FY2010 Loss as Revenues Rise 26 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Following on last week's announcement of preliminary financial results, Clinical Data today reported flat fourth-quarter revenue growth and an increased net loss on higher R&D spending.

The Newton, Mass.-based firm reported a 26 percent increase in its full-year revenues compared to fiscal-year 2009 and sharp decrease in its net loss year over year.

Clinical Data reported revenues of $3.2 million for the quarter ended March 31, flat with the fourth quarter of 2009.

Its net loss was $38.4 million, or $1.44 per share, compared with a net loss of $23.9 million, or $1.05 per share, for Q4 2009.

The firm's R&D spending more than doubled to $26.7 million from $12.8 million, while its SG&A expenses jumped to $10.9 million from $7.1 million. The 2009 Q4 results included a $2 million charge for purchased in-process R&D.

Clinical Data reported fiscal-year 2010 revenues of $13.1 million, up from $10.4 million.

Its net loss for the year fell sharply to $88.5 million, or $3.57 per share, from $132.4 million, or $6.03 per share. The decrease was due primarily to a charge of $55.1 million in FY2009 for purchased in-process R&D.

The firm's R&D spending increased to $56.8 million from $44.1 million, while its SG&A spending increased to $31.8 million from $27.5 million.

Clinical Data finished the quarter with $49.2 million in cash and cash equivalents.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.